Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Latest News about Cybin
Recent news which mentions Cybin
Cybin: Positive Data Announced From Innovative Drug Trial
March 02, 2023
Tags
Cybin
General
Market News
From
Benzinga
Cybin: Psychedelic Based BioPharma Company To Announce Much Anticipated Updates For Its Ongoing Clinical Trials
February 27, 2023
Tags
Market News
General
Interview
From
Benzinga
Cybin Approved For First In-Human Dosing Of DMT Molecule CYB004, Milestone For Anxiety Disorder Treatment
February 01, 2023
Tickers
CYBN
DMT
Tags
CYBN
Doug Drysdale
Psychedelics
From
Benzinga
Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family
September 27, 2022
Tickers
CYBN
MSSTF
Tags
Doug Drysdale
CYBN
Benzinga
From
Benzinga
BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression
August 17, 2022
Tickers
CYBN
DEA
MDD
Tags
Doug Drysdale
Clinilabs
Legal
From
Benzinga
This Psychedelics Company Is Setting Up An Equity Program For Up To $35M In Shares
August 09, 2022
Tickers
CYBN
SEC
Tags
Cannabis
Market News
Offerings
From
Benzinga
How Does Ketamine Affect The Brain Over Time?
June 25, 2022
Tags
contributors
Psychedelics
Benzinga
From
Benzinga
Cybin Presents "Why Cybin Is Investing So Heavily On Developing Novel Psychedelic Molecules" At The Psychedelic Capital Conference
April 25, 2022
Tickers
CYBN
Tags
Cybin
Psychedelics
Penny Stocks
From
Benzinga
Cybin's Major Depressive Disorder Treatment Trials Continue With Clinilabs Drug Development Corp
April 22, 2022
Tickers
CYBN
Tags
News
Cybin
Clinilabs Drug Development Corporation
From
Benzinga
Cybin's CYB0004 Shows Positive Preclinical Results Over Traditional Psychedelics
April 13, 2022
Tickers
CYBN
Tags
Cannabis
Market News
CYBN
From
Benzinga
WIPO Publishes Cybin's Patent Application For Inhaled Psychedelics Therapies
April 08, 2022
Tickers
CYBN
Tags
Cybin
News
Psychedelics
From
Benzinga
A Builder From The Ground Up, Doug Drysdale, CEO of Cybin: Meet Our Speakers
April 06, 2022
Tickers
AGN
CYBN
PTX
Tags
Benzinga
Psychedelics
AGN
From
Benzinga
Cybin Begins Study Using Kernel Flow Headsets To Measure Ketamine's Effects On The Brain
March 31, 2022
Tickers
CYBN
Tags
Psychedelics
Benzinga
Ketamine
From
Benzinga
Cybin Completes In Vivo Preclinical Studies For Major Depressive Disorder
March 29, 2022
Tickers
CYBN
Tags
Cannabis
Market News
Markets
From
Benzinga
Five Companies Developing Second Generation Psychedelics For Mental Health
March 24, 2022
Tickers
CYBN
ENVB
FTRP
MNMD
Tags
Psychedelics
Benzinga
MindMed
From
Benzinga
Cybin Reports Q2 Financial Results And Latest News, Including FDA & DEA Research Approvals
November 15, 2021
Tickers
CYBN
Tags
Cybin
News
Benzinga
From
Benzinga
Cybin Announces Positive Data Showing Effectiveness of Psilocybin To Treat Depression
November 08, 2021
Tickers
CYBN
Tags
Markets
Market News
Cannabis
From
Benzinga
Cybin: FDA Authorizes Feasibility Study To Measure Ketamine's Effect On Cerebral Cortex
October 27, 2021
Tickers
CYBN
Tags
Interview
Benzinga
Biotech
From
Benzinga
Cybin Inc. (NEO: CYBN) (NYSE: CYBN) Files Two International Patent Applications In Support Of The Company's Research Phase Programs
August 19, 2021
Tickers
CYBN
Tags
CYBN
Partner Content
General
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.